Abstract
Functional near-infrared spectroscopy (fNIRS) enables the noninvasive measurement of human brain activity by monitoring concentration changes of oxygenated hemoglobin (O2Hb) and deoxygenated hemoglobin (HHb) in the blood.1 – 4 fNIRS has evolved from a tool for basic research to a widely used technique to investigate brain activity in nonconstrained environments.5,6 Despite its versatile use, there remain several challenges, in particular, the sensitivity of continuous-wave fNIRS to hemodynamic changes of non-neuronal origin.2,7 – 10 These are often referred to as physiological “noise” or “interference” and include systemic activities, such as cardiac pulsation (1 to 2 Hz), respiration (0.2 to 0.4 Hz), low-frequency oscillations (∼0.1  Hz) and very low-frequency oscillations (0.01 to 0.05 Hz),11 and an increase in blood flow through sympathetic nervous activity.12 These artifacts generate signal changes that may mimic or mask true task-evoked hemodynamic responses (HRs) and may lead to false positives or false negatives.8,10,13 This challenge has been acknowledged and its significance recognized in the recent years by the fNIRS community.8 Although the susceptibility to non-neuronal signals is specific to the measurement principle of fNIRS, all technologies that infer brain activity via hemodynamic changes, i.e., fNIRS, functional magnetic resonance imaging, and positron emission tomography, are affected.

This publication has 75 references indexed in Scilit: